Profil
Martin Erixon formerly worked at Hamlet BioPharma AB, as Chief Executive Officer from 2022 to 2023, Hamlet BioPharma AB, as Chief Executive Officer from 2023 to 2025, Gambro AB, as Manager-Research & Development Project, and Tetra Pak AB, as Manager-Research & Development Project from 2011 to 2022.
Mr. Erixon received his doctorate degree in 2007 from the University of Lund.
Tidigare kända positioner av Martin Erixon
| Företag | Position | Slut |
|---|---|---|
| HAMLET PHARMA AB (PUBL) | Verkställande Direktör | 2025-02-18 |
| HAMLET PHARMA AB (PUBL) | Verkställande Direktör | 2023-10-01 |
Tetra Pak AB
Tetra Pak AB Pulp & PaperProcess Industries Manufactures laminated paperboard materials and related packaging products | Företagsledare/Principal | 2022-06-01 |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Företagsledare/Principal | - |
Martin Erixons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetra Pak AB
Tetra Pak AB Pulp & PaperProcess Industries Manufactures laminated paperboard materials and related packaging products | Process Industries |
Hamlet BioPharma AB
Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients | Health Technology |
















